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IMMUNOLOGY
HLA Correlates of Long-Term Survival in Vertically Infected
HIV-1-Positive Adolescents in Harare, Zimbabwe
Brittany L. Shepherd,1 Rashida Ferrand,2,3 Shungu Munyati,3 Samuel Folkard,1 Kathryn Boyd,3
Tsitsi Bandason,3 Sabelle Jallow,1 Sarah L. Rowland-Jones,1 and Louis-Marie Yindom1
Abstract
African infants with vertically acquired HIV infection progress rapidly, with only 50% surviving beyond 2
years in the absence of treatment. Despite this high initial mortality, recent reports describe a substantial burden
of older children living with untreated vertically acquired HIV infection in Southern Africa. The immunological
and genetic factors associated with long-term survival following vertical infection are poorly understood. We
performed medium-to-high resolution HLA typing on DNA samples obtained from a cohort of presumed
vertically HIV-1-infected children and age-matched uninfected controls in Harare, Zimbabwe. Overall, 93 HLA
class I alleles were detected in the study population with a significant enrichment of HLA-C*08:02 and
-C*08:04 in the HIV-1-infected long-term survivor group. Conversely, HLA-A*02:01, A*34:02, and -B*58:02
were overrepresented in the uninfected control group. Our data indicate that HLA alleles may have differential
effects against HIV acquisition and disease progression in vertical HIV-1 infection.
Globally, 35.3 million people were estimated to beliving with HIV infection in 2012.1 Southern Africa
remains the worst affected region with adult HIV prevalence
rates exceeding 20% in some countries2: this rate is even
higher among pregnant women.1 Without intervention the
risk of mother-to-child transmission (MTCT) of HIV is 25–
35%, which has resulted in a regional epidemic of vertically
acquired HIV, in parallel to the adult epidemic, that has had a
major impact on child mortality.1,3
Unlike adults, in which the median time from HIV infec-
tion to development of AIDS is about 10 years, the natural
history of HIV in infants is dominated by high rates of rapid
disease progression with a 50% probability of survival by the
age of 2 years in African cohorts.4–6 As a result, survival into
adolescence without antiretroviral treatment was considered
rare in Africa. However, recent reports have revealed that up
to one-third of HIV-infected infants have more slowly pro-
gressive disease with mean survival rates ranging from 8 to
16 years of age.7–10
Population-based surveys of older children in Southern
Africa report high HIV prevalence rates of 2–6% among
older children and young adults.11 Although many untreated
HIV + adolescents present with severe disease manifesta-
tions, predominantly respiratory and cardiac, initial studies
suggest that a small proportion (5–10%) of newly diagnosed
presumed vertically infected HIV + adolescents in Harare,
Zimbabwe have no symptoms and a normal CD4 + count,12
and could be termed long-term slow-progressors (LTSP).
Further studies in the now sizable group of adolescents who
have survived long term with vertical HIV-1 infection may
provide important information about immune correlates of
delayed disease progression following acquisition of HIV
infection in infancy.
To date, there have been few studies to identify the genetic
determinants of long-term survival following vertical ac-
quisition of HIV-1 infection in African adolescents. The
highly polymorphic human leukocyte antigen (HLA) gene
network on chromosome 6 is strongly predictive of adult
HIV-1 infection outcomes,13 with striking associations be-
tween HLA alleles and viral control.14 HIV-1-infected adults
with ‘‘protective’’ HLA class I alleles who go on to exhibit
spontaneous viral control show rapid viral clearance in acute
HIV-1 infection.15 In contrast vertically infected infants have
very high peak viral loads (VL) in the first few months of life
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that decline only slowly16: there is no obvious ‘‘controller’’
group in infant HIV-1 infection, raising the question of
whether the HLA alleles linked with viral control in adults
mediate a similar effect in children.
One previous study in a relatively small population of 61
HIV-infected children in Durban, South Africa showed that
slow progression was associated with possession of at least
one of three predefined ‘‘protective’’ class I HLA alleles
(B*57:03, B*58:01, B*81:01), particularly when these were
not shared with the mother17: however, these children were
not followed into adolescence. A better understanding of the
role played by host immunogenetic factors in the long-term
control of vertical HIV-1 infection could lead to the design of
new therapeutic and preventive strategies for pediatric HIV-1
infection.
We sought to identify the HLA correlates of delayed pe-
diatric HIV-1 disease progression using samples previously
collected from a cohort of 123 children and adolescents aged
10–18 years old with (presumed) vertically acquired HIV-1
infection and 276 age-matched uninfected controls recruited
from public hospitals and primary health care clinics in
Harare, Zimbabwe, as previously described.12,18 Vertical
HIV infection was assumed to be the most likely source of
infection on the basis of criteria developed in Zimbabwe:
these include self-report of no sexual debut or blood trans-
fusions, a history of maternal or natural sibling HIV disease/
death, and characteristic clinical features of longstanding
HIV [ ‡ 1 of stunting; history of recurrent minor infections
(skin, upper respiratory tract)].
The clinical samples were collected as part of a study fo-
cusing on the diagnosis and care of older children with pre-
viously undiagnosed HIV-1 infection,12,18 hence at
recruitment the majority of HIV + participants were not tak-
ing antiretroviral therapy (ART). The ideal comparison group
would have been untreated vertically infected rapid pro-
gressors infected with HIV-1 contemporaneously with the
slow progressors: however, these children inevitably had died
well before the start of this study. We reasoned that the en-
richment of specific HLA alleles in the HIV + group com-
pared to healthy controls would be the result of either
increased susceptibility to HIV-1 infection or (more likely) a
survival advantage. The study was approved by the Medical
Research Council of Zimbabwe (MRCZ), the Biomedical
Research and Training Institute (BRTI) IRB, the Harare
Hospital Ethics Committee, and the Oxford Tropical Re-
search Ethics Committee (OxTREC). Informed consent/as-
sent was obtained from each participant/guardian, and
participants largely belonged to the Shona ethnic group.
HLA class I genotypingwas performed by sequencing using
locus-specific primers and the BigDye Terminator Cycle Se-
quencing Ready reaction kit (Applied Biosystems, Foster city,
CA) as previously described.19,20
Overall, we identified 30 HLA-A, 37 HLA-B, and 26
HLA-C subtypes, with the most frequent being A*30:02
(25.7%), B*53:01 (19.4%), and C*04:01 (25.2%), respec-
tively. Figure 1 depicts the assignment of HLA class I alleles
(present at > 3% frequency in this population) between the
long-term survivors of vertical HIV-1 infection and the un-
infected controls. Alleles present at significantly increased
frequency in the control population include HLA-A*02:01,
-A*34:02, and -B*58:02: of note, HLA-B*58:02 has previ-
ously been linked to rapid disease progression in African
populations (Zambians and Rwandans).21 The only alleles
showing significant enrichment in the slow progressors were
HLA-C alleles, C*08:02 and C*08:04. There was a trend to
enrichment for B*57:03, which is strongly linked with delayed
disease progression inAfrican adults,21,22 but this did not reach
significance in our study (Supplementary Table S1; Supple-
mentaryData are available online atwww.liebertpub.com/aid).
These data show that HLA-C*08:02 and C*08:04 are
significantly enriched in the HIV-1 long-term survivor group,
and may therefore confer a survival advantage following
vertical infection (Fig. 1). These alleles have not previously
been linked with either progression or disease susceptibility
FIG. 1. Distribution of HLA
class I alleles between infected
and uninfected groups. Only
alleles with an overall fre-
quency > 3% of the study
population are represented.
*Differences remained signif-
icant after Bonferroni correc-
tion for multiple comparisons.
p-values estimated using Chi-
squared or Fisher’s exact test
as appropriate.
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in other cohorts. The level of cell surface expression of some
HLA-C alleles is strongly linked with delayed disease pro-
gression,23 suggesting that HIV-specific T cells restricted by
HLA-C molecules may contribute to viral control: however,
in this study HLA-C*08:02 was in the middle of the range for
HLA-C expression. Alternatively, as ligands for natural killer
(NK) cell recognition, HLA-C molecules may contribute to
HIV control through NK cell activity: HLA-C*08 alleles
belong to the C group 2 allele family, and would therefore be
expected to bind to the two domains inhibitory killer im-
munoglobulin-like receptors (KIRs) 2DL2 and 2DL3. KIR
typing and further investigations into potential mechanisms
by which HLA-C*08:02 and C*08:04 may contribute to HIV
control will be addressed in future studies.
In a large population study, it was shown that HLA-
influenced viral polymorphisms correlated with higher viral
loads. In the same study, escape mutants were associated with
the most prevalent class I allele in most populations, HLA-
A*02:01.24 This indicates that HLA immune pressure may
lead to the evolution of circulating HIV variants that are able
to avoid detection by the most common HLA alleles, which,
in turn, contributes to the failure of the immune system to
control viral replication. In a mixed American population, a
strong relationship was found between rapid disease pro-
gression in children and the presence of the HLA-A*23:01
allele, but a discordant effect of HLA-A*02:01 alleles in the
black and white ethnic groups was noted.17,25 In our study,
HLA-A*02:01, A*34:02, and HLA-B*58:02 were signifi-
cantly overrepresented in the uninfected group: this could
indicate that these alleles have a beneficial effect against HIV
acquisition, but most immunogenetic studies on HIV infec-
tion have reported much stronger links between HLA alleles
and disease progression than either resistance or suscepti-
bility to HIV acquisition. Alternatively, the relatively low
frequencies of these alleles in the long-term survivor group
could reflect associations with rapid progression to AIDS and
early death following vertical HIV-1 transmission. Further
investigation in well-established pediatric cohorts, in which
both rapid and slow progressors can be reliably characterized,
will be required to resolve this issue.
Host genetic factors have been shown to have a profound
impact on antigen presentation and immune responses,
greatly influencing HIV pathogenesis and progression to
AIDS. The HLA class I region, the most polymorphic region
of the human genome, has a stronger association with HIV
disease outcome than any other group of genes. Here, we
provide the HLA class I gene profiles of a population of
adolescent long-term survivors of HIV-1 infection that serve
as an essential first step for further study design to elucidate
the immunological and genetic factors mediating delayed
disease progression in a minority of African children with
vertically acquired HIV-1 infection.
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